Indications for IVUS (Data Review & Appropriate Use Criteria)

↳ This is a section part of Moment: The role of IVUS in Contemporary PCI

Add this Moment to your Passport

Learn from this moment and keep it forever.
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Preview

Open uri20161107 16515 15b5n1o?1478540580

Summary

To aid our viewers to follow the topics discussed please see the following guidance:


Time Discussion Point - Discussant


00.00-00.30 Introduction - Sharp

00.30-10.30 Left Main - Legutko/Sharp/Di Mario/Akasaka/O'Kane

10.30-20.19 Stent Optimisation - Akasaka/Sharp/O'Kane/Di Mario/Legutko

20.19-25.19 CTO - Di Mario/Sharp/Akasaka

25.19-30.59 Diffuse/Calcified Disease  - O'Kane/Sharp/Legutko/Di Mario

30.59-31.16 Session summary - Sharp

Add this Moment to your Passport

Learn from this moment and keep it forever.
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Target Audience

This educational activity is intended for an international audience, specifically interventional cardiologists and cardiologists. However, other healthcare professionals involved in the care of coronary artery disease (CAD) patients will also find this topical.

Learning Objectives

The assigned learning objectives for this roundtable are listed for your information:

To increase awareness, understanding and adoption of IVUS technology  

  • To educate on clinical utilisation of IVUS in specific indications 
  • To review current clinical trial data and discuss gaps 
  • To analyse use of IVUS in the assessment of complications
Loading Simple Education